Literature DB >> 24631683

Modulation of PGC-1α activity as a treatment for metabolic and muscle-related diseases.

Kristoffer Svensson1, Christoph Handschin2.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24631683     DOI: 10.1016/j.drudis.2014.02.013

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


× No keyword cloud information.
  5 in total

1.  Small molecule PGC-1α1 protein stabilizers induce adipocyte Ucp1 expression and uncoupled mitochondrial respiration.

Authors:  A T Pettersson-Klein; M Izadi; D M S Ferreira; I Cervenka; J C Correia; V Martinez-Redondo; M Southern; M Cameron; T Kamenecka; L Z Agudelo; M Porsmyr-Palmertz; U Martens; B Lundgren; M Otrocka; A Jenmalm-Jensen; P R Griffin; J L Ruas
Journal:  Mol Metab       Date:  2018-02-03       Impact factor: 7.422

2.  FNDC5 expression closely correlates with muscle fiber types in porcine longissimus dorsi muscle and regulates myosin heavy chains (MyHCs) mRNA expression in C2C12 cells.

Authors:  Xiao-Ming Men; Zi-Wei Xu; Xin Tao; Bo Deng; Ke-Ke Qi
Journal:  PeerJ       Date:  2021-04-19       Impact factor: 2.984

Review 3.  Muscle Wasting Diseases: Novel Targets and Treatments.

Authors:  Regula Furrer; Christoph Handschin
Journal:  Annu Rev Pharmacol Toxicol       Date:  2018-08-27       Impact factor: 13.820

Review 4.  Skeletal muscle as an endocrine organ: PGC-1α, myokines and exercise.

Authors:  Svenia Schnyder; Christoph Handschin
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

Review 5.  Complex Coordination of Cell Plasticity by a PGC-1α-controlled Transcriptional Network in Skeletal Muscle.

Authors:  Barbara Kupr; Christoph Handschin
Journal:  Front Physiol       Date:  2015-11-09       Impact factor: 4.566

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.